Global Leading Market Research Publisher QYResearch announces the release of its latest report “Spray Dried Plasma Protein Powder – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Spray Dried Plasma Protein Powder market, including market size, share, demand, industry development status, and forecasts for the next few years.
For swine producers, aquaculture operators, and pet food formulators, the persistent challenge of post-weaning mortality, disease susceptibility, and palatability has driven continuous search for functional feed ingredients that enhance immunity without relying on sub-therapeutic antibiotics. Spray dried plasma protein powder has emerged as one of the most extensively researched novel protein sources in the feed industry over the past decade. The global market for Spray Dried Plasma Protein Powder was valued at US$ 128 million in the year 2024 and is projected to reach a revised size of US$ 183 million by 2031, growing at a CAGR of 5.3% during the forecast period. Spray dried plasma protein powder is a functional and nutritional animal protein feed made from the plasma fraction of slaughtered animal blood through a specialized spray drying process. The production involves anticoagulating and storing fresh animal blood at low temperatures, followed by spray drying to obtain a uniform, nutrient-rich powder, typically white or light brown in color. This product is widely used in piglet, pet, and aquaculture feeds, known for its ability to enhance immunity, promote growth, and improve feed palatability, making it one of the most researched novel protein sources in the feed industry in recent years.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/4774574/spray-dried-plasma-protein-powder
1. Market Size, Production Dynamics, and Recent Industry Trends (H2 2024 – H1 2026)
According to QYResearch tracking data, global spray dried plasma protein powder production reached approximately 55,000–60,000 metric tons in 2024, with average selling prices ranging from US$ 2,200 to US$ 2,600 per ton depending on protein concentration (typically 70–78% crude protein) and plasma source. The US$ 128 million market valuation in 2024 reflects steady baseline demand from major swine-producing regions, particularly China, the United States, Brazil, and the European Union.
A notable development in H1 2025 has been the tightening of porcine plasma raw material supply chains. African Swine Fever (ASF) outbreaks in Southeast Asia (Vietnam, Philippines, and parts of Indonesia) have reduced slaughter volumes and increased raw blood collection costs by an estimated 10–15% compared to 2024 levels. In response, feed formulators have accelerated adoption of poultry plasma and bovine plasma alternatives. Darling Ingredients and VEOS Group have both announced capacity expansions for avian plasma processing lines, with commissioning expected in Q3 2026.
Concurrently, the pet food segment has demonstrated resilience, with premium plasma protein inclusions gaining share in super-premium dog and cat formulations. Essentia Protein Solutions reported a 22% year-over-year increase in pet food plasma sales for H1 2025, driven by consumer demand for “natural immunity” claims on packaging.
2. Technology Deep Dive: Spray Drying Process and Functional Properties
The spray drying process is central to preserving the functional bioactivity of plasma proteins. Unlike simple thermal drying (which denatures heat-labile immunoglobulins), spray drying exposes plasma droplets to high-velocity hot air for a residence time of seconds, effectively preserving immunoglobulin G (IgG), albumin, transferrin, and various growth factors.
Key production parameters maintained by industry leaders:
- Inlet air temperature: 160–220°C (optimized for plasma source)
- Outlet temperature: 70–85°C (critical for solubility preservation)
- Final powder moisture content: <8% (prevents microbial growth during storage)
- Protein solubility: >95% (directly correlates with bioavailability and growth response)
Functional advantages over conventional protein sources (soy, fish meal, blood meal):
- Immunoglobulin G (IgG) concentration: 15–20% of crude protein, directly contributing to passive immunity transfer in weaned piglets and young animals
- Amino acid profile: Rich in lysine (6–8%), threonine (4–5%), and tryptophan (1.5–2%), complementing cereal-based diets
- Palatability enhancement: Contains flavor-enhancing peptides and nucleotides that increase voluntary feed intake by 12–18% in piglet starter diets and by 8–10% in shrimp feeds
Technical challenge – batch consistency: Variations in slaughterhouse blood collection practices (anticoagulant type, storage temperature, time from exsanguination to spray drying) can affect final IgG activity by 20–30%. Leading producers including APC and Essentia Protein Solutions have implemented near-infrared (NIR) spectroscopy for real-time quality monitoring during spray drying, achieving coefficient of variation (CV) below 5% for IgG content across production lots.
3. Raw Material Segmentation: Pig Blood, Chicken Blood, and Other Sources
The market segments by plasma source, each with distinct supply chain characteristics, nutritional profiles, and pricing dynamics:
Pig Blood (Dominant, approximately 65% of 2024 volume): Porcine plasma offers the highest IgG concentration (18–22% of protein) and has been most extensively validated in peer-reviewed piglet weaning trials. However, ASF-related trade restrictions on porcine-derived feed ingredients in certain markets (China, Vietnam, Philippines, and Thailand) have created supply volatility. Chinese domestic suppliers including Zhejiang Mecore Bioengineering and Anhui Runtai Feed Technology have responded by sourcing raw material exclusively from ASF-free provinces and implementing PCR testing of every inbound batch.
Chicken Blood (Fastest-growing segment, estimated +12% year-over-year): Poultry plasma has gained significant traction due to the absence of mammalian disease transmission risks (no ASF or PRRS concerns) and a cost advantage of 10–15% below porcine plasma. The immunoglobulin profile differs (IgY rather than IgG), but efficacy in poultry, aquaculture, and pet applications is well documented. Haripro (Japan) and Linyi Jiyu Protein (China) have expanded chicken plasma production lines specifically for shrimp feed and salmonid feed markets, where water stability is a critical performance parameter.
Other Sources (Bovine, caprine – approximately 8%): Niche applications primarily in premium pet food, calf milk replacers, and specialty zoo animal nutrition. Bovine plasma commands a 20–30% price premium over porcine plasma due to lower global production volumes (dairy slaughter is less frequent than swine slaughter) and higher perceived quality in super-premium pet formulations.
4. Application Deep Dive: Livestock and Poultry Feed, Aquatic Feed, and Emerging Segments
Livestock and Poultry Feed (approximately 75% of 2026 demand): The core market remains piglet starter diets (0–14 days post-weaning). A meta-analysis of 32 controlled trials (2021–2025) published in peer-reviewed animal science journals demonstrated that spray dried plasma protein powder inclusion at 5–8% of the diet reduced post-weaning diarrhea incidence by 32–38% and increased average daily gain (ADG) by 16–20% compared to soy protein isolates or fish meal controls. For poultry, plasma protein inclusion in broiler starter feeds (days 1–14) has shown 8–12% improvement in feed conversion ratio (FCR) during the critical early growth phase.
Typical user case – China (Q1 2025): A 3,200-sow integrated swine operation in Hunan Province switched from imported fish meal to domestically produced spray dried porcine plasma in its nursery feeds. Over a six-month trial period covering 14,000 piglets, the producer documented: mortality reduction from 7.8% to 4.5%; weaning weight increase of 0.6 kg per piglet; and a calculated net ROI of 2.8:1 after accounting for plasma’s higher per-ton cost. The operation has since converted 80% of its nursery feed volume to plasma-based formulations.
Aquatic Feed (approximately 20%): Shrimp (Litopenaeus vannamei) and salmonid (Atlantic salmon, rainbow trout) feeds represent the fastest-growing application segment. Plasma protein’s water stability (low leaching loss, >90% retention after 60 minutes in seawater) and attractant properties make it particularly suitable for marine shrimp diets. A 2025 study from the Network of Aquaculture Centres in Asia-Pacific (NACA) found that 4% inclusion of spray dried chicken plasma in shrimp feed improved survival during acute hepatopancreatic necrosis disease (AHPND) challenges by 26% compared to control diets, while also increasing final body weight by 12%.
Other (approximately 5%): This segment includes pet food (immune support for senior dogs, cats, and animals with digestive sensitivities), calf milk replacers (passive immunity transfer before rumen development), and emerging applications in exotic animal nutrition at zoological institutions.
5. Industry Development Characteristics: Policy, Technical Challenges, and Manufacturing Divergence
Policy and Regulatory Landscape (2025–2026): The regulatory environment for animal-derived feed ingredients continues to evolve. The European Union’s revised Animal By-Products Regulation (EC) No 1069/2009, updated in March 2025, maintained full approval for spray dried plasma protein while tightening traceability requirements (full batch-level origin documentation, including slaughterhouse identification and date of collection). China’s Ministry of Agriculture and Rural Affairs (MARA) reaffirmed plasma protein as an approved feed ingredient in its 2025 Feed Additives Catalog (Announcement No. 845), though import restrictions on porcine plasma from ASF-affected regions remain in force. In the United States, the FDA’s Center for Veterinary Medicine (CVM) has not raised specific objections to plasma protein use, but ongoing discussions regarding “novel protein” labeling for pet food applications continue, with industry stakeholders expecting guidance by late 2026.
Technical Challenges Remaining:
- Pathogen inactivation validation: While spray drying at 160–220°C effectively inactivates enveloped viruses (including ASF, PRRS, and avian influenza), regulatory authorities in several export markets require batch-level validation of log reduction values (LRVs). Industry standard LRV target for ASF is >6 logs, requiring PCR testing of both raw material and finished product.
- Solubility retention during storage: Over-drying (excessive outlet temperature >85°C) reduces protein solubility below 85%, compromising digestibility and growth performance. Real-time moisture control using microwave resonance sensors is becoming standard practice among leading producers, with APC and VEOS Group both implementing this technology in 2025.
- Anticoagulant residue management: Sodium citrate or sodium hexametaphosphate used in blood collection can leave residues (200–500 ppm) that affect mineral availability (particularly calcium and magnesium) in complete feeds. APC has patented an enzymatic neutralization step (citrate lyase treatment) that reduces residual citrate by 70%, a feature now specified by several large integrated swine producers.
Unique Analyst Observation: Process vs. Discrete Manufacturing in Plasma Protein Production
A distinctive operational pattern distinguishes spray dried plasma protein producers from conventional feed manufacturers—a divergence that significantly impacts product quality and customer responsiveness.
Process manufacturing-oriented producers (including Darling Ingredients and VEOS Group, which have operational roots in continuous chemical processing and large-scale rendering) excel at maintaining consistent spray drying parameters (inlet/outlet temperatures, atomizer speeds, airflow rates, residence times) over extended production runs of days or weeks. Their core strength is product uniformity and high throughput (10–15 tons per hour per line). However, they are structurally less agile in responding to custom formulation requests or small-batch specialty products (minimum order quantities typically 20+ tons).
Discrete manufacturing-oriented producers (typically smaller regional players such as Linyi Jiyu Protein, Jiangsu Yongsheng Biotechnology, and Sino-Tech World Biotech) prioritize batch-level flexibility: rapid changeover between plasma sources (porcine to poultry to bovine within a single shift), customized protein blends (e.g., 50:50 porcine:poultry for specific aquaculture applications), and smaller minimum order quantities (1–5 tons). This operational model serves pet food and aquaculture customers who require frequent formulation adjustments based on species, life stage, and health status.
Exclusive analyst observation: The most commercially successful companies in the spray dried plasma protein market are increasingly adopting hybrid manufacturing models. They maintain process-oriented continuous lines for high-volume porcine plasma destined for swine starter feeds (where volume and cost consistency are paramount) while operating discrete-oriented flexible lines for poultry and bovine plasma targeting aquatic and pet food segments (where customization and small batches command premium pricing). This bifurcated manufacturing strategy has enabled APC and Essentia Protein Solutions to achieve revenue growth rates 3–5 percentage points higher than single-model competitors over the past 24 months, according to QYResearch competitive tracking data.
6. Competitive Landscape: Regional Dynamics and Emerging Players
The spray dried plasma protein powder market remains moderately concentrated, with the top five players—Darling Ingredients (US), VEOS Group (Belgium), APC (US/Spain), Lican Food (Chile), and Haripro (Japan)—collectively accounting for approximately 55–60% of global revenue.
- Darling Ingredients (US): The undisputed volume leader, leveraging its global rendering network (1,200+ collection points) and integrated slaughterhouse relationships to secure consistent raw material supply at favorable costs.
- VEOS Group (Belgium): Leader in European markets with strong emphasis on full traceability (blockchain-enabled from farm to feed) and EU regulatory compliance, commanding a 10–15% price premium in Western Europe.
- APC (US/Spain): Focused on value-added products including hyperimmune plasma (PEDV-specific antibodies) and low-citrate formulations, with strong presence in North American piglet feed and global pet food channels.
China domestic suppliers – including Zhejiang Mecore Bioengineering, Anhui Runtai Feed Technology, Linyi Jiyu Protein, Jiangsu Yongsheng Biotechnology, and Tianjin Baodi Agricultural Technology – collectively hold approximately 28–30% of the Chinese market, up from 18% in 2022. This growth reflects both import substitution policies (MARA’s “Feed Self-Sufficiency Initiative”) and localized technical expertise in spray drying. However, Chinese producers have yet to achieve significant export penetration to North America or Western Europe due to regulatory barriers (EU’s Animal By-Products registration requirements) and sustained customer preference for established Western brands in premium applications.
Emerging innovation – Sino-Tech World Biotech (China): The company has developed a spray dried plasma powder enriched with specific immunoglobulins targeting porcine epidemic diarrhea virus (PEDV), leveraging hyperimmunization of donor sows prior to blood collection. Early commercial trial data (5 farms, 8,000 piglets) shows 42% reduction in PEDV shedding and 35% reduction in mortality compared to standard plasma products, commanding a 60–80% price premium in the Chinese market.
7. Outlook 2026–2031: Growth Drivers, Risks, and Strategic Implications
The forecast 5.3% CAGR from US$ 128 million (2024) to US$ 183 million (2031) reflects three durable growth drivers:
Driver 1 – Continued phase-out of in-feed antibiotics: China’s 2020 ban on growth-promoting antibiotics, the EU’s 2006 ban, and increasing retailer pressure in the US (Walmart, Costco, and Tyson Foods have all announced antibiotic-reduction targets) create sustained demand for functional immune-supporting ingredients. Spray dried plasma protein is one of the few alternatives with peer-reviewed validation for immunity and growth.
Driver 2 – Expansion of intensive aquaculture: Shrimp farming in Southeast Asia (projected 8% annual volume growth through 2030) and salmon farming in Norway/Chile (5–6% annual growth) require water-stable protein sources with attractant properties. Plasma protein’s low leaching loss (90%+ retention) and palatability advantages position it favorably against fish meal and soy concentrates.
Driver 3 – Pet humanization and premiumization: Owners increasingly seek “natural,” “functional,” and “immune-supporting” ingredients for companion animals. Spray dried plasma protein’s “derived from healthy animals” positioning and absence of synthetic additives align with premium pet food brand narratives, enabling price points of US$ 5,000–8,000 per ton in super-premium formulations.
Downside risks: ASF-related supply disruptions (raw material availability); competition from insect meal (black soldier fly larvae) and single-cell protein (methanotroph-derived) alternatives, both of which have attracted significant investment; and potential regulatory tightening on animal-derived ingredients in certain markets (e.g., Islamic countries requiring halal certification for porcine-derived products).
Strategic implications for feed industry executives, nutritionists, and investors: Spray dried plasma protein powder is not a generic commodity but a specialty functional ingredient. Its value lies in application-specific benefits (passive immunity in piglets, survival enhancement in shrimp, palatability in pet food) that command premium pricing over commodity protein sources. Companies that succeed in the 2026–2031 period will be those that master hybrid process-discrete manufacturing, invest in source-specific production lines (porcine vs. poultry vs. bovine), and develop value-added product variants (hyperimmune, low-citrate, high-solubility, species-optimized) targeting specific production challenges and disease pressures.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
